List of Tables
    Table 1. Seasonal Influenza Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Seasonal Influenza Vaccines Market Trends
    Table 3. Seasonal Influenza Vaccines Market Drivers
    Table 4. Seasonal Influenza Vaccines Market Challenges
    Table 5. Seasonal Influenza Vaccines Market Restraints
    Table 6. Global Seasonal Influenza Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Seasonal Influenza Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Seasonal Influenza Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Seasonal Influenza Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Seasonal Influenza Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Seasonal Influenza Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Seasonal Influenza Vaccines Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Seasonal Influenza Vaccines Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Seasonal Influenza Vaccines Sales Share by Manufacturer, 2017-2022
    Table 15. Global Seasonal Influenza Vaccines Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Seasonal Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Seasonal Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines as of 2021)
    Table 18. Top Players of Seasonal Influenza Vaccines in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Seasonal Influenza Vaccines Product Type
    Table 20. Date of International Manufacturers Enter into Seasonal Influenza Vaccines Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Seasonal Influenza Vaccines Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Seasonal Influenza Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Seasonal Influenza Vaccines Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Seasonal Influenza Vaccines Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Seasonal Influenza Vaccines Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Seasonal Influenza Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Seasonal Influenza Vaccines Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Seasonal Influenza Vaccines Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Seasonal Influenza Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Seasonal Influenza Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Seasonal Influenza Vaccines Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Seasonal Influenza Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Seasonal Influenza Vaccines Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Seasonal Influenza Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Seasonal Influenza Vaccines Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Seasonal Influenza Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Seasonal Influenza Vaccines Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Seasonal Influenza Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Seasonal Influenza Vaccines Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Seasonal Influenza Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. GlaxoSmithKline plc Corporation Information
    Table 43. GlaxoSmithKline plc Description and Business Overview
    Table 44. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. GlaxoSmithKline plc Seasonal Influenza Vaccines Product
    Table 46. GlaxoSmithKline plc Recent Development
    Table 47. Sinovac Biotech Ltd Corporation Information
    Table 48. Sinovac Biotech Ltd Description and Business Overview
    Table 49. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Sinovac Biotech Ltd Product
    Table 51. Sinovac Biotech Ltd Recent Development
    Table 52. Changsheng Bio-Technology Corporation Information
    Table 53. Changsheng Bio-Technology Description and Business Overview
    Table 54. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Changsheng Bio-Technology Product
    Table 56. Changsheng Bio-Technology Recent Development
    Table 57. Ccbio SA Corporation Information
    Table 58. Ccbio SA Description and Business Overview
    Table 59. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Ccbio SA Product
    Table 61. Ccbio SA Recent Development
    Table 62. Aleph Biomedical Corporation Information
    Table 63. Aleph Biomedical Description and Business Overview
    Table 64. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Aleph Biomedical Product
    Table 66. Aleph Biomedical Recent Development
    Table 67. Sanofi Corporation Information
    Table 68. Sanofi Description and Business Overview
    Table 69. Sanofi Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Sanofi Product
    Table 71. Sanofi Recent Development
    Table 72. Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
    Table 73. Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Business Overview
    Table 74. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Jiangsu Simcere Vaxtec Bio-pharmaceutical Product
    Table 76. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Development
    Table 77. Dalian Hissen Bio-pharm Corporation Information
    Table 78. Dalian Hissen Bio-pharm Description and Business Overview
    Table 79. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Dalian Hissen Bio-pharm Product
    Table 81. Dalian Hissen Bio-pharm Recent Development
    Table 82. Abbott Laboratories Corporation Information
    Table 83. Abbott Laboratories Description and Business Overview
    Table 84. Abbott Laboratories Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Abbott Laboratories Product
    Table 86. Abbott Laboratories Recent Development
    Table 87. Novartis International AG Corporation Information
    Table 88. Novartis International AG Description and Business Overview
    Table 89. Novartis International AG Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Novartis International AG Product
    Table 91. Novartis International AG Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Seasonal Influenza Vaccines Customers List
    Table 95. Seasonal Influenza Vaccines Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Seasonal Influenza Vaccines Product Picture
    Figure 2. Global Seasonal Influenza Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Seasonal Influenza Vaccines Market Size 2017-2028 (US$ Million)
    Figure 4. Global Seasonal Influenza Vaccines Sales 2017-2028 (K Units)
    Figure 5. United States Seasonal Influenza Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Seasonal Influenza Vaccines Market Size 2017-2028 (US$ Million)
    Figure 7. United States Seasonal Influenza Vaccines Sales 2017-2028 (K Units)
    Figure 8. United States Seasonal Influenza Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Seasonal Influenza Vaccines Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Seasonal Influenza Vaccines Report Years Considered
    Figure 11. Product Picture of Type A (H1N1)
    Figure 12. Product Picture of Type A (H3N2)
    Figure 13. Product Picture of Type B
    Figure 14. Global Seasonal Influenza Vaccines Market Share by Type in 2022 & 2028
    Figure 15. Global Seasonal Influenza Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Seasonal Influenza Vaccines Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Seasonal Influenza Vaccines Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Seasonal Influenza Vaccines Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Seasonal Influenza Vaccines Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Seasonal Influenza Vaccines Market Share by Type in 2022 & 2028
    Figure 21. United States Seasonal Influenza Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Seasonal Influenza Vaccines Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Seasonal Influenza Vaccines Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Seasonal Influenza Vaccines Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Seasonal Influenza Vaccines Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Pediatrics
    Figure 27. Product Picture of Adolescence
    Figure 28. Product Picture of Adults
    Figure 29. Product Picture of Elderly
    Figure 30. Global Seasonal Influenza Vaccines Market Share by Application in 2022 & 2028
    Figure 31. Global Seasonal Influenza Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Seasonal Influenza Vaccines Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Seasonal Influenza Vaccines Sales by Application (2017-2028) & (K Units)
    Figure 34. Global Seasonal Influenza Vaccines Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Seasonal Influenza Vaccines Price by Application (2017-2028) & (USD/Unit)
    Figure 36. United States Seasonal Influenza Vaccines Market Share by Application in 2022 & 2028
    Figure 37. United States Seasonal Influenza Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Seasonal Influenza Vaccines Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Seasonal Influenza Vaccines Sales by Application (2017-2028) & (K Units)
    Figure 40. United States Seasonal Influenza Vaccines Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Seasonal Influenza Vaccines Price by Application (2017-2028) & (USD/Unit)
    Figure 42. North America Seasonal Influenza Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 43. North America Seasonal Influenza Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Seasonal Influenza Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 47. Europe Seasonal Influenza Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Seasonal Influenza Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 54. Asia-Pacific Seasonal Influenza Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Seasonal Influenza Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 66. Latin America Seasonal Influenza Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Seasonal Influenza Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 71. Middle East & Africa Seasonal Influenza Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Seasonal Influenza Vaccines Value Chain
    Figure 76. Seasonal Influenza Vaccines Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed